National Pension Service Raises Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Key Points

• The National Pension Service increased its holdings in Johnson & Johnson by 5.9% in Q1, owning 4,857,219 shares worth approximately $805 million.
• Wall Street analysts have varying ratings for the stock, with the majority rating it a "Moderate Buy", and price targets ranging from $175 to $190.
• Johnson & Johnson recently declared a quarterly dividend of $1.30 per share, representing a 3.0% yield and a dividend payout ratio of 55.61%.

National Pension Service lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 5.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,857,219 shares of the company's stock after purchasing an additional 270,729 shares during the period. Johnson & Johnson comprises approximately 0.8% of National Pension Service's investment portfolio, making the stock its 23rd largest holding. National Pension Service owned 0.20% of Johnson & Johnson worth $805,521,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Elios Financial Group Inc. raised its stake in Johnson & Johnson by 1.5% in the 1st quarter. Elios Financial Group Inc. now owns 4,496 shares of the company's stock valued at $746,000 after acquiring an additional 66 shares during the period. Atlantic Family Wealth LLC grew its holdings in Johnson & Johnson by 4.4% during the 1st quarter. Atlantic Family Wealth LLC now owns 1,603 shares of the company's stock valued at $266,000 after buying an additional 67 shares in the last quarter. MBA Advisors LLC grew its holdings in Johnson & Johnson by 1.2% during the 1st quarter. MBA Advisors LLC now owns 5,553 shares of the company's stock valued at $921,000 after buying an additional 68 shares in the last quarter. Sovereign Financial Group Inc. raised its holdings in shares of Johnson & Johnson by 1.8% in the 1st quarter. Sovereign Financial Group Inc. now owns 3,928 shares of the company's stock valued at $651,000 after acquiring an additional 69 shares in the last quarter. Finally, Nabity Jensen Investment Management Inc grew its holdings in shares of Johnson & Johnson by 1.5% during the first quarter. Nabity Jensen Investment Management Inc now owns 4,624 shares of the company's stock worth $767,000 after purchasing an additional 69 shares in the last quarter. 69.55% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Benchmark raised Johnson & Johnson to a "strong-buy" rating in a research note on Thursday, April 24th. Leerink Partners lowered Johnson & Johnson from an "outperform" rating to a "market perform" rating and dropped their price objective for the company from $169.00 to $153.00 in a research note on Tuesday, May 13th. Royal Bank Of Canada increased their price objective on Johnson & Johnson from $181.00 to $185.00 and gave the company an "outperform" rating in a research note on Thursday, July 17th. Leerink Partnrs lowered Johnson & Johnson from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, May 13th. Finally, Piper Sandler reissued an "overweight" rating on shares of Johnson & Johnson in a research note on Thursday, July 17th. Nine analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $174.50.

Johnson & Johnson Stock Up 1.2%

JNJ traded up $2.04 during trading on Friday, reaching $176.76. The stock had a trading volume of 9,476,237 shares, compared to its average volume of 8,427,234. The stock's 50 day moving average is $161.28 and its two-hundred day moving average is $158.34. The company has a current ratio of 1.01, a quick ratio of 0.76 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $425.70 billion, a price-to-earnings ratio of 18.90, a P/E/G ratio of 2.23 and a beta of 0.41. Johnson & Johnson has a one year low of $140.68 and a one year high of $177.27.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings data on Wednesday, July 16th. The company reported $2.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.68 by $0.09. The business had revenue of $23.74 billion during the quarter, compared to the consensus estimate of $22.85 billion. Johnson & Johnson had a return on equity of 32.49% and a net margin of 25.00%. The firm's quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.82 earnings per share. As a group, analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 26th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, August 26th. Johnson & Johnson's dividend payout ratio is currently 55.61%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.